Dusheiko, Geoffrey;
Agarwal, Kosh;
Maini, Mala K;
(2023)
New Approaches to Chronic Hepatitis B.
New England Journal of Medicine
, 388
pp. 55-69.
10.1056/NEJMra2211764.
Preview |
Text
Maini_nejmra2211764.pdf Download (2MB) | Preview |
Abstract
Chronic hepatitis B is caused by the hepatitis B virus (HBV), a hepatotropic DNA virus that can replicate at high levels and cause minimal disease or severe liver injury. The clinical spectrum of chronic hepatitis B ranges from no symptoms to progressive hepatic fibrosis, advanced cirrhosis, and hepatocellular carcinoma. An estimated 296 million people have chronic hepatitis B, of whom 221 million live in low- and middle-income countries. Without intervention, deaths from HBV are expected to peak at 1.14 million by 2035.
| Type: | Article |
|---|---|
| Title: | New Approaches to Chronic Hepatitis B |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1056/NEJMra2211764 |
| Publisher version: | http://doi.org/10.1056/NEJMra2211764 |
| Language: | English |
| Additional information: | This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10165159 |
Archive Staff Only
 |
View Item |
